Find a Tender
planning
Official procurement procedure
Soft Market Testing - Supply of Nicotine-free medication products approved for stop smoking support including: Cytisinicline (Cytisine), Varenicline and Bupropion.
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: North Northamptonshire Council: "Soft Market Testing - Supply of Nicotine-free medication products approved for stop smoking support including: Cytisinicline (Cytisine), Varenicline and Bupropion.". Published status: planning. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | North Northamptonshire Council | Scope & Categories | Not published | Submission Window | planning No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: North Northamptonshire Council
Market Analytics
Derived from OCDS awards & bid statistics
Published history for North Northamptonshire Council. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
7.1%Historical Average
Competition Density
26.8Bids / Report
Supplier ConcentrationModerate Concentration
ASHTONS HOSPITAL PHARMACY SERVICES LIMITEDTop vendor: 32.8% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 232 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| ASHTONS HOSPITAL PHARMACY SERVICES LIMITED | 1 win | £937,923 |
| P McVey Building Systems | 1 win | £860,540 |
| J & B ELECTRICAL LIMITED | 1 win | £234,949 |
| PLACECUBE LIMITED | 1 win | £200,000 |
| MEMORIA LIMITED | 1 win | £146,000 |
Procedure terms
Contracting AuthorityNorth Northamptonshire Council | Procedure methodNot published | Procurement categoryNot published |
Statusplanning | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published25 Sept 2025, 09:39 BST | Last source update25 Sept 2025, 09:39 BST | Recurring procurementNot published |
ClassificationHealth services | ||
OCIDocds-h6vhtk-05a150 | ||
What is being bought
North Northamptonshire Council (NNC) Public Health Team is exploring options for the future supply and distribution of nicotine- free medicine products. To support our local smoking cessation services. We are particularly interested in understanding the market position on pharmacological treatments such as Cytisinicline (Cytisine), Varenicline and Bupropion.
We are keen to explore the capacity of potential suppliers to deliver products direct-to-client and undertake online models of
consultation and assessment of clients. Here the provider would manage clinical governance (including PGD arrangements).
Notice:
This is not a formal procurement process. The purpose of this soft market engagement is to:
• Gauge supplier interest in potential future opportunities.
• Understand online service models, supply capacity and distribution models (direct-to-client delivery).
• Explore the availability and licensing status of Cytisinicline, Varenicline and Bupropion.
• Inform the development of an online stop smoking medicines provision for any future procurement.
Scope of Products (indicative):
• Cytisinicline (Cytisine)
• Varenicline
• Bupropion
What changed
From the official release history
- Official notice release published
25 Sept 2025, 09:39 BST - Status changed to planning
24 Sept 2025, 15:29 BST - Official notice release published
24 Sept 2025, 15:29 BST - Buyer information updated
24 Sept 2025, 15:29 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplanningPublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Pipeline notice
25 Sept 2025, 09:39 BST - Procedure published
25 Sept 2025, 09:39 BST - engagement
15 Oct 2025, 23:59 BST · scheduledInterested suppliers are invited to provide answers to a short questionnaire which can be accessed via the following link : https://forms.office.com/Pages/ResponsePage.aspx?id=-Q6c4geaAku5i3stinjXN0XmezY99pdLqwaOehYqgU9UOUhOVVpDTDA2OU1PSFVKUzBaODE3TTBQUy4u Interested suppliers should kindly click above to complete the expression of interest form. If you wish to provide any additional supporting information or documents, these may be submitted within the completed questionnaire, or alternatively these can be submitted via email to: nnc-PublicHealthCommissioningTeam@northnorthants.gov.uk by 15/10/2025. Kindly ensure to use ''Stop Cessation Medication Soft Market Testing'' as the subject of the email.
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
North Northamptonshire Council
Contracting authority GB-PPON-PQCM-5634-HGCNDocuments (1)
Official links; attachments are not copied
- 25 Sept 2025, 09:39 BST
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |